Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 50

1.

Next-generation sequencing and biomarkers for gastric cancer: what is the future?

Kawazoe A, Shitara K.

Ther Adv Med Oncol. 2019 Jun 21;11:1758835919848189. doi: 10.1177/1758835919848189. eCollection 2019. Review.

2.

PD-1+ regulatory T cells amplified by PD-1 blockade promote hyperprogression of cancer.

Kamada T, Togashi Y, Tay C, Ha D, Sasaki A, Nakamura Y, Sato E, Fukuoka S, Tada Y, Tanaka A, Morikawa H, Kawazoe A, Kinoshita T, Shitara K, Sakaguchi S, Nishikawa H.

Proc Natl Acad Sci U S A. 2019 May 14;116(20):9999-10008. doi: 10.1073/pnas.1822001116. Epub 2019 Apr 26.

3.

Dawn of precision medicine on gastric cancer.

Ishii T, Kawazoe A, Shitara K.

Int J Clin Oncol. 2019 Jul;24(7):779-788. doi: 10.1007/s10147-019-01441-x. Epub 2019 Apr 11. Review.

PMID:
30976939
4.

Dynamics and Perception in the Thermal Grill Illusion.

Patwardhan S, Kawazoe A, Kerr D, Nakatani M, Visell Y.

IEEE Trans Haptics. 2019 Mar 11. doi: 10.1109/TOH.2019.2904226. [Epub ahead of print]

PMID:
30869631
5.

Clinicopathological and molecular features of responders to nivolumab for patients with advanced gastric cancer.

Mishima S, Kawazoe A, Nakamura Y, Sasaki A, Kotani D, Kuboki Y, Bando H, Kojima T, Doi T, Ohtsu A, Yoshino T, Kuwata T, Tsuji A, Shitara K.

J Immunother Cancer. 2019 Jan 31;7(1):24. doi: 10.1186/s40425-019-0514-3.

6.

First-in-Human Phase I Study of an Oral HSP90 Inhibitor, TAS-116, in Patients with Advanced Solid Tumors.

Shimomura A, Yamamoto N, Kondo S, Fujiwara Y, Suzuki S, Yanagitani N, Horiike A, Kitazono S, Ohyanagi F, Doi T, Kuboki Y, Kawazoe A, Shitara K, Ohno I, Banerji U, Sundar R, Ohkubo S, Calleja EM, Nishio M.

Mol Cancer Ther. 2019 Mar;18(3):531-540. doi: 10.1158/1535-7163.MCT-18-0831. Epub 2019 Jan 24.

PMID:
30679388
7.

Predictive factors for hyperprogressive disease during nivolumab as anti-PD1 treatment in patients with advanced gastric cancer.

Sasaki A, Nakamura Y, Mishima S, Kawazoe A, Kuboki Y, Bando H, Kojima T, Doi T, Ohtsu A, Yoshino T, Kuwata T, Akimoto T, Shitara K.

Gastric Cancer. 2019 Jul;22(4):793-802. doi: 10.1007/s10120-018-00922-8. Epub 2019 Jan 9.

PMID:
30627987
8.

Efficacy and safety of ramucirumab-containing chemotherapy in patients with pretreated metastatic gastric neuroendocrine carcinoma.

Mishima S, Kawazoe A, Matsumoto H, Kuboki Y, Bando H, Kojima T, Doi T, Ohtsu A, Yoshino T, Nonte EM, Chintharlapalli S, Nasir A, Kuwata T, Shitara K.

ESMO Open. 2018 Nov 1;3(7):e000443. doi: 10.1136/esmoopen-2018-000443. eCollection 2018.

9.

Four cases of paradoxical cephalocervical pyogenic granuloma during treatment with paclitaxel and ramucirumab.

Watanabe R, Nakano E, Kawazoe A, Kuboki Y, Bando H, Shitara K, Takahashi A, Tsutsumida A, Nishizawa A, Yamazaki N.

J Dermatol. 2019 May;46(5):e178-e180. doi: 10.1111/1346-8138.14693. Epub 2018 Oct 31. No abstract available.

PMID:
30379358
10.

Targeting VEGFR2 with Ramucirumab strongly impacts effector/ activated regulatory T cells and CD8+ T cells in the tumor microenvironment.

Tada Y, Togashi Y, Kotani D, Kuwata T, Sato E, Kawazoe A, Doi T, Wada H, Nishikawa H, Shitara K.

J Immunother Cancer. 2018 Oct 11;6(1):106. doi: 10.1186/s40425-018-0403-1.

11.

Clinical practice guidance for next-generation sequencing in cancer diagnosis and treatment (Edition 1.0).

Sunami K, Takahashi H, Tsuchihara K, Takeda M, Suzuki T, Naito Y, Sakai K, Dosaka-Akita H, Ishioka C, Kodera Y, Muto M, Wakai T, Yamazaki K, Yasui W, Bando H, Fujimoto Y, Fukuoka S, Harano K, Kawazoe A, Kimura G, Koganemaru S, Kogawa T, Kotani D, Kuboki Y, Matsumoto H, Matsumoto S, Mishima S, Nakamura Y, Sawada K, Shingaki S, Shitara K, Umemoto K, Umemura S, Yasuda K, Yoshino T, Yamamoto N, Nishio K; Japanese Society of Medical Oncology; Japan Society of Clinical Oncology; Japanese Cancer Association.

Cancer Sci. 2018 Sep;109(9):2980-2985. doi: 10.1111/cas.13730.

12.

Clinicopathological features of 22C3 PD-L1 expression with mismatch repair, Epstein-Barr virus status, and cancer genome alterations in metastatic gastric cancer.

Kawazoe A, Shitara K, Kuboki Y, Bando H, Kojima T, Yoshino T, Ohtsu A, Ochiai A, Togashi Y, Nishikawa H, Doi T, Kuwata T.

Gastric Cancer. 2019 Jan;22(1):69-76. doi: 10.1007/s10120-018-0843-9. Epub 2018 Jun 1.

PMID:
29859006
13.

Tuberculous Meningitis during Chemotherapy for Advanced Gastric Cancer.

Matsumoto H, Sasaki A, Nakamura Y, Kawazoe A, Kuboki Y, Okinaka K, Shitara K.

Case Rep Oncol. 2018 Apr 5;11(1):228-233. doi: 10.1159/000488313. eCollection 2018 Jan-Apr.

14.

Population Pharmacokinetic Analysis of Busulfan in Japanese Pediatric and Adult HCT Patients.

Kawazoe A, Funaki T, Kim S.

J Clin Pharmacol. 2018 Sep;58(9):1196-1204. doi: 10.1002/jcph.1120. Epub 2018 Apr 17.

PMID:
29663421
15.

A retrospective study of the safety and efficacy of paclitaxel plus ramucirumab in patients with advanced or recurrent gastric cancer with ascites.

Matsumoto H, Kawazoe A, Shimada K, Fukuoka S, Kuboki Y, Bando H, Kojima T, Ohtsu A, Yoshino T, Doi T, Shitara K.

BMC Cancer. 2018 Jan 31;18(1):120. doi: 10.1186/s12885-018-4057-7.

16.

[Cytotoxic Agents and Immune Checkpoint Inhibitors].

Kawazoe A, Shitara K.

Gan To Kagaku Ryoho. 2017 Sep;44(9):717-721. Japanese.

PMID:
28912395
17.

The novel heme-dependent inducible protein, SRRD regulates heme biosynthesis and circadian rhythms.

Adachi Y, Umeda M, Kawazoe A, Sato T, Ohkawa Y, Kitajima S, Izawa S, Sagami I, Taketani S.

Arch Biochem Biophys. 2017 Oct 1;631:19-29. doi: 10.1016/j.abb.2017.08.006. Epub 2017 Aug 9.

PMID:
28802827
18.

Validation of the American Gastroenterological Association guidelines on management of intraductal papillary mucinous neoplasms: more than 5 years of follow-up.

Imbe K, Nagata N, Hisada Y, Takasaki Y, Sekine K, Mishima S, Kawazoe A, Tajima T, Shimbo T, Yanase M, Akiyama J, Fujimoto K, Uemura N.

Eur Radiol. 2018 Jan;28(1):170-178. doi: 10.1007/s00330-017-4966-x. Epub 2017 Aug 2.

PMID:
28770404
19.

Prophylactic Use of Oral Dexamethasone to Alleviate Fatigue During Regorafenib Treatment for Patients With Metastatic Colorectal Cancer.

Fukuoka S, Shitara K, Noguchi M, Kawazoe A, Kuboki Y, Bando H, Okamoto W, Kojima T, Doi T, Ohtsu A, Yoshino T.

Clin Colorectal Cancer. 2017 Jun;16(2):e39-e44. doi: 10.1016/j.clcc.2016.07.012. Epub 2016 Aug 18.

PMID:
27780748
20.

Clinicopathological features of programmed death ligand 1 expression with tumor-infiltrating lymphocyte, mismatch repair, and Epstein-Barr virus status in a large cohort of gastric cancer patients.

Kawazoe A, Kuwata T, Kuboki Y, Shitara K, Nagatsuma AK, Aizawa M, Yoshino T, Doi T, Ohtsu A, Ochiai A.

Gastric Cancer. 2017 May;20(3):407-415. doi: 10.1007/s10120-016-0631-3. Epub 2016 Sep 14.

PMID:
27629881
21.

Safety and Efficacy of Trifluridine/Tipiracil Monotherapy in Clinical Practice for Patients With Metastatic Colorectal Cancer: Experience at a Single Institution.

Kotani D, Shitara K, Kawazoe A, Fukuoka S, Kuboki Y, Bando H, Okamoto W, Kojima T, Doi T, Ohtsu A, Yoshino T.

Clin Colorectal Cancer. 2016 Sep;15(3):e109-15. doi: 10.1016/j.clcc.2015.11.005. Epub 2015 Nov 27.

PMID:
26723516
22.

Development of Pancreatic Cancer, Disease-specific Mortality, and All-Cause Mortality in Patients with Nonresected IPMNs: A Long-term Cohort Study.

Nagata N, Kawazoe A, Mishima S, Wada T, Shimbo T, Sekine K, Watanabe K, Imbe K, Kojima Y, Kumazawa K, Mihara F, Tokuhara M, Edamoto Y, Igari T, Yanase M, Mizokami M, Akiyama J, Uemura N.

Radiology. 2016 Jan;278(1):125-34. doi: 10.1148/radiol.2015150131. Epub 2015 Jul 13.

PMID:
26172534
23.

A retrospective observational study of clinicopathological features of KRAS, NRAS, BRAF and PIK3CA mutations in Japanese patients with metastatic colorectal cancer.

Kawazoe A, Shitara K, Fukuoka S, Kuboki Y, Bando H, Okamoto W, Kojima T, Fuse N, Yamanaka T, Doi T, Ohtsu A, Yoshino T.

BMC Cancer. 2015 Apr 11;15:258. doi: 10.1186/s12885-015-1276-z.

24.

Clinical outcomes in 66 patients with advanced gastric cancer treated in phase I trials: the NCCHE experience.

Kawazoe A, Shitara K, Fukuoka S, Noguchi M, Kuboki Y, Bando H, Okamoto W, Kojima T, Fuse N, Yoshino T, Ohtsu A, Doi T.

Invest New Drugs. 2015 Jun;33(3):664-70. doi: 10.1007/s10637-015-0231-9. Epub 2015 Mar 15.

PMID:
25773493
25.

p53 directly regulates the transcription of the human frataxin gene and its lack of regulation in tumor cells decreases the utilization of mitochondrial iron.

Shimizu R, Lan NN, Tai TT, Adachi Y, Kawazoe A, Mu A, Taketani S.

Gene. 2014 Nov 1;551(1):79-85. doi: 10.1016/j.gene.2014.08.043. Epub 2014 Aug 23.

PMID:
25158131
26.

Lactoferrin inhibits infection-related osteoclastogenesis without interrupting compressive force-related osteoclastogenesis.

Inubushi T, Kawazoe A, Miyauchi M, Yanagisawa S, Subarnbhesaj A, Chanbora C, Ayuningtyas NF, Ishikado A, Tanaka E, Takata T.

Arch Oral Biol. 2014 Feb;59(2):226-32. doi: 10.1016/j.archoralbio.2013.11.002. Epub 2013 Dec 1.

PMID:
24370195
27.

Congenital Erythropoietic Porphyria: Mutation of the Uroporphyrinogen III Cosynthase Gene in a Vietnamese Patient.

Thien Kim DH, Kawazoe A, Bang PD, Thanh NT, Taketani S.

Case Rep Dermatol. 2013 Mar 27;5(1):105-10. doi: 10.1159/000350679. Print 2013 Jan.

28.

Ultrasound stimulation attenuates resorption of tooth root induced by experimental force application.

Inubushi T, Tanaka E, Rego EB, Ohtani J, Kawazoe A, Tanne K, Miyauchi M, Takata T.

Bone. 2013 Apr;53(2):497-506. doi: 10.1016/j.bone.2013.01.021. Epub 2013 Jan 19.

PMID:
23337039
29.

Orally administered liposomal lactoferrin inhibits inflammation-related bone breakdown without interrupting orthodontic tooth movement.

Kawazoe A, Inubushi T, Miyauchi M, Ishikado A, Tanaka E, Tanne K, Takata T.

J Periodontol. 2013 Oct;84(10):1454-62. doi: 10.1902/jop.2012.120508. Epub 2012 Nov 8.

PMID:
23136974
30.

Fulminant amebic colitis with an atypical clinical presentation successfully treated by metronidazole.

Kawazoe A, Nagata N.

Clin Gastroenterol Hepatol. 2012 Nov;10(11):e91. doi: 10.1016/j.cgh.2012.06.035. Epub 2012 Jul 17. No abstract available.

PMID:
22813444
31.

Psychological impact of the pandemic (H1N1) 2009 on general hospital workers in Kobe.

Matsuishi K, Kawazoe A, Imai H, Ito A, Mouri K, Kitamura N, Miyake K, Mino K, Isobe M, Takamiya S, Hitokoto H, Mita T.

Psychiatry Clin Neurosci. 2012 Jun;66(4):353-60. doi: 10.1111/j.1440-1819.2012.02336.x.

32.

Molecular mechanisms of the inhibitory effects of bovine lactoferrin on lipopolysaccharide-mediated osteoclastogenesis.

Inubushi T, Kawazoe A, Miyauchi M, Kudo Y, Ao M, Ishikado A, Makino T, Takata T.

J Biol Chem. 2012 Jul 6;287(28):23527-36. doi: 10.1074/jbc.M111.324673. Epub 2012 May 16.

33.

Intestinal tuberculosis in an HIV-infected patient with advanced immunosuppression.

Kawazoe A, Nagata N.

Clin Gastroenterol Hepatol. 2012 Sep;10(9):A24. doi: 10.1016/j.cgh.2012.03.013. Epub 2012 Mar 31. No abstract available.

PMID:
22469991
34.

Effect of PGE₂ induced by compressive and tensile stresses on cementoblast differentiation in vitro.

Rego EB, Inubushi T, Kawazoe A, Miyauchi M, Tanaka E, Takata T, Tanne K.

Arch Oral Biol. 2011 Nov;56(11):1238-46. doi: 10.1016/j.archoralbio.2011.05.007. Epub 2011 Jun 22.

PMID:
21700269
35.

Treatment of a case of skeletal class II malocclusion with temporomandibular joint disorder using miniscrew anchorage.

Kaku M, Koseki H, Kawazoe A, Abedini S, Kojima S, Motokawa M, Ohtani J, Fujita T, Kawata T, Tanne K.

Cranio. 2011 Apr;29(2):155-63.

PMID:
21661590
36.

Ultrasound stimulation attenuates root resorption of rat replanted molars and impairs tumor necrosis factor-α signaling in vitro.

Rego EB, Inubushi T, Miyauchi M, Kawazoe A, Tanaka E, Takata T, Tanne K.

J Periodontal Res. 2011 Dec;46(6):648-54. doi: 10.1111/j.1600-0765.2011.01384.x. Epub 2011 Jun 6.

PMID:
21644998
37.

Factors associated with motivation and hesitation to work among health professionals during a public crisis: a cross sectional study of hospital workers in Japan during the pandemic (H1N1) 2009.

Imai H, Matsuishi K, Ito A, Mouri K, Kitamura N, Akimoto K, Mino K, Kawazoe A, Isobe M, Takamiya S, Mita T.

BMC Public Health. 2010 Nov 4;10:672. doi: 10.1186/1471-2458-10-672.

38.

Developing a disease outbreak event corpus.

Conway M, Kawazoe A, Chanlekha H, Collier N.

J Med Internet Res. 2010 Sep 28;12(3):e43. doi: 10.2196/jmir.1323.

39.

Ultrasound stimulation induces PGE(2) synthesis promoting cementoblastic differentiation through EP2/EP4 receptor pathway.

Rego EB, Inubushi T, Kawazoe A, Tanimoto K, Miyauchi M, Tanaka E, Takata T, Tanne K.

Ultrasound Med Biol. 2010 Jun;36(6):907-15. doi: 10.1016/j.ultrasmedbio.2010.03.008. Epub 2010 May 5.

PMID:
20447753
40.

Inhibitory effects of orally administrated liposomal bovine lactoferrin on the LPS-induced osteoclastogenesis.

Yamano E, Miyauchi M, Furusyo H, Kawazoe A, Ishikado A, Makino T, Tanne K, Tanaka E, Takata T.

Lab Invest. 2010 Aug;90(8):1236-46. doi: 10.1038/labinvest.2010.80. Epub 2010 Apr 26.

41.

Correction of severe open bite using miniscrew anchorage.

Kaku M, Kawai A, Koseki H, Abedini S, Kawazoe A, Sasamoto T, Sunagawa H, Yamamoto R, Tsuka N, Motokawa M, Ohtani J, Fujita T, Kawata T, Tanne K.

Aust Dent J. 2009 Dec;54(4):374-80. doi: 10.1111/j.1834-7819.2009.01166.x.

42.

A framework for enhancing spatial and temporal granularity in report-based health surveillance systems.

Chanlekha H, Kawazoe A, Collier N.

BMC Med Inform Decis Mak. 2010 Jan 12;10:1. doi: 10.1186/1472-6947-10-1.

43.

Classifying disease outbreak reports using n-grams and semantic features.

Conway M, Doan S, Kawazoe A, Collier N.

Int J Med Inform. 2009 Dec;78(12):e47-58. doi: 10.1016/j.ijmedinf.2009.03.010. Epub 2009 May 15.

PMID:
19447070
44.

Towards role-based filtering of disease outbreak reports.

Doan S, Kawazoe A, Conway M, Collier N.

J Biomed Inform. 2009 Oct;42(5):773-80. doi: 10.1016/j.jbi.2008.12.009. Epub 2008 Dec 31.

45.

An adolescent patient with multiple impacted teeth.

Tanaka E, Kawazoe A, Nakamura S, Ito G, Hirose N, Tanne Y, Kawai N, Tanimoto K, Tanne K.

Angle Orthod. 2008 Nov;78(6):1110-8. doi: 10.2319/121007-581.1.

PMID:
18947292
46.

BioCaster: detecting public health rumors with a Web-based text mining system.

Collier N, Doan S, Kawazoe A, Goodwin RM, Conway M, Tateno Y, Ngo QH, Dien D, Kawtrakul A, Takeuchi K, Shigematsu M, Taniguchi K.

Bioinformatics. 2008 Dec 15;24(24):2940-1. doi: 10.1093/bioinformatics/btn534. Epub 2008 Oct 15.

47.

Effects of ultrasound on the proliferation and differentiation of cementoblast lineage cells.

Inubushi T, Tanaka E, Rego EB, Kitagawa M, Kawazoe A, Ohta A, Okada H, Koolstra JH, Miyauchi M, Takata T, Tanne K.

J Periodontol. 2008 Oct;79(10):1984-90. doi: 10.1902/jop.2008.080081 .

PMID:
18834255
48.

Structuring an event ontology for disease outbreak detection.

Kawazoe A, Chanlekha H, Shigematsu M, Collier N.

BMC Bioinformatics. 2008 Apr 11;9 Suppl 3:S8. doi: 10.1186/1471-2105-9-S3-S8.

49.

Dynamic shear behavior of mandibular condylar cartilage is dependent on testing direction.

Tanaka E, Iwabuchi Y, Rego EB, Koolstra JH, Yamano E, Hasegawa T, Kawazoe A, Kawai N, Tanne K.

J Biomech. 2008;41(5):1119-23. doi: 10.1016/j.jbiomech.2007.12.012. Epub 2008 Feb 1.

PMID:
18242620
50.

Topological properties of an SU(3) gauge system near the critical temperature on an anisotropic lattice.

Hashimoto T, Hioki S, Hirose K, Kanki T, Kawazoe A, Masujima M, Miyamura O, Osada Y.

Phys Rev D Part Fields. 1990 Jul 15;42(2):620-629. No abstract available.

PMID:
10012880

Supplemental Content

Loading ...
Support Center